These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 38786051
1. Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats. Greco R, Demartini C, Francavilla M, Zanaboni AM, Facchetti S, Palmisani M, Franco V, Tassorelli C. Cells; 2024 May 13; 13(10):. PubMed ID: 38786051 [Abstract] [Full Text] [Related]
2. Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Greco R, Demartini C, Zanaboni A, Casini I, De Icco R, Reggiani A, Misto A, Piomelli D, Tassorelli C. Neurobiol Dis; 2021 Jan 13; 147():105157. PubMed ID: 33129939 [Abstract] [Full Text] [Related]
3. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain. Della Pietra A, Krivoshein G, Ivanov K, Giniatullina R, Jyrkkänen HK, Leinonen V, Lehtonen M, van den Maagdenberg AMJM, Savinainen J, Giniatullin R. J Headache Pain; 2023 Apr 11; 24(1):38. PubMed ID: 37038131 [Abstract] [Full Text] [Related]
5. Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine. Greco R, Demartini C, Zanaboni AM, Francavilla M, Reggiani A, Realini N, Scarpelli R, Piomelli D, Tassorelli C. J Headache Pain; 2022 Jul 07; 23(1):79. PubMed ID: 35799128 [Abstract] [Full Text] [Related]
6. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine. Greco R, Francavilla M, Demartini C, Zanaboni AM, Sodergren MH, Facchetti S, Pacchetti B, Palmisani M, Franco V, Tassorelli C. J Headache Pain; 2023 May 03; 24(1):48. PubMed ID: 37138206 [Abstract] [Full Text] [Related]
7. Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Greco R, Demartini C, Francavilla M, Zanaboni AM, Tassorelli C. Cells; 2021 Sep 26; 10(10):. PubMed ID: 34685523 [Abstract] [Full Text] [Related]
8. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Della Pietra A, Giniatullin R, Savinainen JR. Int J Mol Sci; 2021 Jan 26; 22(3):. PubMed ID: 33530477 [Abstract] [Full Text] [Related]
10. Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. Greco R, Demartini C, Zanaboni AM, Tassorelli C. J Headache Pain; 2018 Jul 13; 19(1):51. PubMed ID: 30003352 [Abstract] [Full Text] [Related]
11. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine. Greco R, Demartini C, Francavilla M, Zanaboni AM, Tassorelli C. Cells; 2022 Sep 30; 11(19):. PubMed ID: 36231054 [Abstract] [Full Text] [Related]
14. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study. Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C. Neurobiol Dis; 2020 Feb 30; 134():104624. PubMed ID: 31629892 [Abstract] [Full Text] [Related]
19. Effects of peripheral FAAH blockade on NTG-induced hyperalgesia--evaluation of URB937 in an animal model of migraine. Greco R, Bandiera T, Mangione AS, Demartini C, Siani F, Nappi G, Sandrini G, Guijarro A, Armirotti A, Piomelli D, Tassorelli C. Cephalalgia; 2015 Oct 23; 35(12):1065-76. PubMed ID: 25608877 [Abstract] [Full Text] [Related]
20. Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat. Greco R, Gasperi V, Sandrini G, Bagetta G, Nappi G, Maccarrone M, Tassorelli C. Cephalalgia; 2010 Mar 23; 30(3):296-302. PubMed ID: 19515121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]